172 related articles for article (PubMed ID: 38555608)
41. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.
Rauf A; Khalil AA; Rahman UU; Khalid A; Naz S; Shariati MA; Rebezov M; Urtecho EZ; de Albuquerque RDDG; Anwar S; Alamri A; Saini RK; Rengasamy KRR
Crit Rev Food Sci Nutr; 2022; 62(22):6034-6054. PubMed ID: 33703960
[TBL] [Abstract][Full Text] [Related]
42. Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus.
Yang Y; Han Z; Gao Z; Chen J; Song C; Xu J; Wang H; Huang A; Shi J; Gu J
Chin Med J (Engl); 2023 Dec; 136(23):2847-2856. PubMed ID: 36959686
[TBL] [Abstract][Full Text] [Related]
43. [Research progress of Eubacterium and its metabolite short-chain fatty acids in regulating type 2 diabetes mellitus].
Li WD; Li LS; Lyu MJ; Hu QY; Xiong DQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jan; 57(1):120-124. PubMed ID: 36655268
[TBL] [Abstract][Full Text] [Related]
44. Polysaccharides from Phellinus linteus attenuate type 2 diabetes mellitus in rats via modulation of gut microbiota and bile acid metabolism.
Liu T; Zhao M; Zhang Y; Xu R; Fu Z; Jin T; Song J; Huang Y; Wang M; Zhao C
Int J Biol Macromol; 2024 Mar; 262(Pt 1):130062. PubMed ID: 38340923
[TBL] [Abstract][Full Text] [Related]
45. Normal Light-Dark and Short-Light Cycles Regulate Intestinal Inflammation, Circulating Short-chain Fatty Acids and Gut Microbiota in
Zhen Y; Ge L; Xu Q; Hu L; Wei W; Huang J; Loor JJ; Yang Q; Wang M; Zhou P
Front Immunol; 2022; 13():848248. PubMed ID: 35371053
[TBL] [Abstract][Full Text] [Related]
46. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
47. Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota.
Lee YS; Lee D; Park GS; Ko SH; Park J; Lee YK; Kang J
Food Funct; 2021 Jul; 12(14):6363-6373. PubMed ID: 34105563
[TBL] [Abstract][Full Text] [Related]
48. Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.
Fusco W; Lorenzo MB; Cintoni M; Porcari S; Rinninella E; Kaitsas F; Lener E; Mele MC; Gasbarrini A; Collado MC; Cammarota G; Ianiro G
Nutrients; 2023 May; 15(9):. PubMed ID: 37432351
[TBL] [Abstract][Full Text] [Related]
49. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
50. Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids.
Jin M; Kalainy S; Baskota N; Chiang D; Deehan EC; McDougall C; Tandon P; Martínez I; Cervera C; Walter J; Abraldes JG
Liver Int; 2019 Aug; 39(8):1437-1447. PubMed ID: 30919578
[TBL] [Abstract][Full Text] [Related]
51. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
52. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
[TBL] [Abstract][Full Text] [Related]
53. Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature.
Li L; Chen L; Yang Y; Wang J; Guo L; An J; Ma X; Lu W; Xiao Y; Wang X; Dong Z
Front Endocrinol (Lausanne); 2022; 13():890200. PubMed ID: 35757432
[TBL] [Abstract][Full Text] [Related]
54. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.
Zhang L; Chu J; Hao W; Zhang J; Li H; Yang C; Yang J; Chen X; Wang H
Mediators Inflamm; 2021; 2021():5110276. PubMed ID: 34447287
[TBL] [Abstract][Full Text] [Related]
55. Antidiabetic action of the Chinese formula Shouhuitongbian and the underlying mechanism associated with alteration of gut microbiota.
Wang T; Liao H; Lin J; Zhang M; Chen B; Yin R; Sun J; Dai H; Liu H
Phytomedicine; 2024 Jul; 129():155575. PubMed ID: 38636179
[TBL] [Abstract][Full Text] [Related]
56. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
[TBL] [Abstract][Full Text] [Related]
57. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
58. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
Gomes S; Rodrigues AC; Pazienza V; Preto A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
[TBL] [Abstract][Full Text] [Related]
59. Hypoglycemic effects of different molecular weight konjac glucomannans via intestinal microbiota and SCFAs mediated mechanism.
Deng J; Zou X; Liang Y; Zhong J; Zhou K; Zhang J; Zhang M; Wang Z; Sun Y; Li M
Int J Biol Macromol; 2023 Apr; 234():122941. PubMed ID: 36563827
[TBL] [Abstract][Full Text] [Related]
60. The Impact of Gut Microbiome on Metabolic Disorders During Catch-Up Growth in Small-for-Gestational-Age.
An J; Wang J; Guo L; Xiao Y; Lu W; Li L; Chen L; Wang X; Dong Z
Front Endocrinol (Lausanne); 2021; 12():630526. PubMed ID: 33746902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
